| Mark Richard Rose, MD | |
|
2801 Franciscan Dr, Bryan, TX 77802-2544 | |
| (979) 776-5967 | |
| (979) 731-5619 |
| Full Name | Mark Richard Rose |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 36 Years |
| Location | 2801 Franciscan Dr, Bryan, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427055102 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center | Merced, CA | Hospital |
| St Joseph Regional Health Center | Bryan, TX | Hospital |
| Baptist Medical Center | San antonio, TX | Hospital |
| Christus Southeast Texas- St Elizabeth | Beaumont, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson Physician Services, Pllc | 0547610677 | 28 |
| St Joseph Regional Health Center | 5294727921 | 159 |
| Questcare Hospitalists Pllc | 5799785119 | 318 |
| Merced Hospitalist Medical Group Inc | 5890948582 | 32 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | St Joseph Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669557179 PECOS PAC ID: 5294727921 Enrollment ID: O20040401000670 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Cogent Healthcare Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20061121000364 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Sound Inpatient Physicians Of Texas I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831424563 PECOS PAC ID: 8729133640 Enrollment ID: O20090828000300 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Ipc Healthcare Services Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023403011 PECOS PAC ID: 3971824939 Enrollment ID: O20150603001409 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Rural Physicians Group-pannu Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891236584 PECOS PAC ID: 0345467486 Enrollment ID: O20180126000519 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas - San Antonio, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174002208 PECOS PAC ID: 7416207873 Enrollment ID: O20180905001955 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas San Marcos Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598244774 PECOS PAC ID: 2961754817 Enrollment ID: O20181004001119 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas - San Antonio Ii Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356987093 PECOS PAC ID: 1557798279 Enrollment ID: O20200219000239 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Hni Physician Services Of Texas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538729744 PECOS PAC ID: 5092128710 Enrollment ID: O20210119000838 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Entity Name | Jefferson Physician Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598546764 PECOS PAC ID: 0547610677 Enrollment ID: O20240102001073 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Richard Rose, MD Po Box 7096, Stockton, CA 95267-0096 Ph: (209) 956-7725 | Mark Richard Rose, MD 2801 Franciscan Dr, Bryan, TX 77802-2544 Ph: (979) 776-5967 |
News Archive
Cell Press launches its new career network to help life scientists discover the best jobs in industry, academia, and government. The new site includes more ways to connect with Cell Press' network of millions of life scientists.
Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
First Pacific Corporation, one of the best kept secrets in dentistry, announced today it has expanded its eTools program as part of its current offering to existing and new clients. This industry leading program allows patients to review their account information at their convenience.
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 4 days ago
Collin Leach, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2801 Franciscan Dr, Bryan, TX 77802 Phone: 979-776-2537 Fax: 979-776-2526 | |
Mrs. Amanda L Goodenow, NP-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2605 Osler Blvd, Bryan, TX 77802 Phone: 512-807-3150 Fax: 512-458-7879 | |
Paige Ann Schmidt, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2900 E 29th St Ste 100, Bryan, TX 77802 Phone: 979-436-0485 |